Hands reaching out with text overlays "LESS waiting", "MORE action", and "MORE than results" over a blurred background of a person on the phone.

Cepheid's Xpert® HCV VL Fingerstick: Results you can trust at point-of-care

Underdiagnosis of hepatitis C remains one of the most significant barriers to HCV elimination and public health, with only 49%–55% of people with chronic HCV aware of their infection status.* In Canada, where the federal government has committed to eliminating hepatitis C as a public health threat by 2030, timely diagnosis and linkage to care remain critical challenges, particularly among underserved and high-risk populations.

 

With its proven scientific accuracy and innovative fingerstick design, the Xpert HCV Viral Load Fingerstick test is transforming how hepatitis C is diagnosed and managed. This point-of-care solution enables healthcare providers to collect a venous or capillary blood sample from patients with positive antibody results, detect acute HCV infections in as little as 60 minutes, and deliver viral load results on-site—all in a single patient visit.

 

By eliminating the need for venipuncture and central lab processing, the Xpert HCV Viral Load Fingerstick test helps reduce the risk of loss to follow-up, save time and resources, and ensure more patients are linked to care and cured. It’s a powerful tool in advancing Canada’s hepatitis C elimination strategy.

 

Xpert HCV VL Fingerstick is a POC test that allows you to:

  • Collect and test fingerstick blood at the point of care (POC)
  • Detect HCV acute infections with viral load in as little as 60 minutes^
  • Reduce the risk of loss to follow-up#x
  • Save time and resources with immediate on-site confirmatory results versus sending out tests#x
 
Xpert(R) HCV Patient Pathway

Benefits of Xpert HCV VL Fingerstick

Xpert HCV VL Fingerstick is a game-changer in hepatitis C care, offering fast, accurate, and accessible viral load testing. With results delivered in under 60 minutes from a simple capillary or venous blood sample, it enables single-visit diagnosis and informed treatment, especially valuable in community and decentralized settings. 

 

Clinicians and patients alike benefit from its high sensitivity and specificity, user-friendly workflow, and minimal training requirements. By supporting point-of-care testing and improving linkage to care, this test plays a critical role in advancing global HCV elimination goals.

Connect with an associate today

Complete the form below to learn more about Xpert HCV Viral Load Fingerstick:

I would like to be part of the Cepheid Community and I understand and consent to receive information about products and services, invitations to virtual and in-person events such as workshops and webinars and educational content from Cepheid and similar information from Cepheid’s affiliates and representatives.

*required fields
Cepheid respects your privacy, and values the relationship with our customers, partners, and associates. Your personal data may be processed by Cepheid, its affiliates, representatives and other Danaher companies for business and marketing purposes. You can review Cepheid Privacy Policy online for additional information on your rights and how we use and share personal data we collect on our websites and other channels. Your consent to receiving Cepheid news can be withdrawn at any time. Building a relationship of trust is important to us and we will happily help with any questions on your personal data processing addressed to Privacy.officer@cepheid.com

Infographic detailing the 3-step workflow for the Xpert HCV VL Fingerstick test, showing sample collection, transfer to cartridge, and insertion into the GeneXpert instrument.

“Rapid HCV RNA tests, which detect HCV genetic material, offer the greatest advantage for diagnosis and rapid initiation of treatment as the presence of HCV RNA confirms current infection.†”

Take Action Now

Contact us today to learn more about how Cepheid Xpert HCV Viral Load Fingerstick can enhance your hepatitis C testing and treatment capabilities.

IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.

* Kimberly Page, Judith Feinberg, What Hepatitis C Virus (HCV) Diagnostic Tools Are Needed to Advance Diagnosis of Current HCV Infection in Outreach Settings and in a Nonclinical Setting, The Journal of Infectious Diseases, Volume 229, Issue Supplement_3, 15 May 2024, Pages S328–S333, https://doi.org/10.1093/infdis/jiad269

^ Refer to the Xpert HCV VL Fingerstick pack insert 303-4689 , Rev A for more information

x Page and Feinberg. What Hepatitis C Virus (HCV) Diagnostic Tools Are Needed to Advance Diagnosis of Current HCV Infection in Outreach Settings and in a Nonclinical Setting JID 2024, https://doi.org/10.1093/infdis/jiad269

# Applegate TL, Fajardo E, Sacks JA. Hepatitis C Virus Diagnosis and the Holy Grail. Infect Dis Clin North Am. 2018;32(2):425-445. doi:10.1016/j.idc.2018.02.010
†  Grebely J, Applegate TL, Cunningham P, Feld JJ. Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis. Expert Rev Mol Diagn 2017; 17:1109–15.

About Cepheid

Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company's solutions deliver actionable results where they are needed most from central laboratories and hospitals to near patient settings.

For more information, visit www.cepheid.com

179 Enterprise Blvd. Ste 300. Markham, ON. L6G 1B3.

©2025 Cepheid. All Rights Reserved.